Cat.#: ACPP-1206
| Despition | ELOVL4 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1244 | SOX2 Blocking Peptide (AC1244) | 250 µg | inquiry |
| ACPP-1512 | Human UBE2K Protein (AC1512) | 2 µg | inquiry |
| ACPP-1276 | MAP3K4 Blocking Peptide (AC1276) | 250 µg | inquiry |
| ACPP-1641 | Adenylate cyclase 1 Blocking Peptide (AC1641) | 250 µg | inquiry |
| ACPP-1542 | Human GSK3B Protein , sf9 (AC1542) | 2 µg | inquiry |
| ACPP-1221 | Bestrophin Blocking Peptide (AC1221) | 250 µg | inquiry |
| ACPP-1617 | Human PARK2 Protein (AC1617) | 5 µg | inquiry |
| ACPP-1718 | Human ASRGL1 Protein (AC1718) | 2 µg | inquiry |
| ACPP-1103 | Rat Leptin Protein (AC1103) | 200 µg | inquiry |
| ACPP-1152 | PAX5 Blocking Peptide (AC1152) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.